Anesthesia for patients with impaired ventricular function

Seminars in Cardiothoracic and Vascular Anesthesia

Volumn 7, Issue 1, 2003, Pages 49-54

  Bovill, J G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; CATECHOLAMINE; DESFLURANE; DIGOXIN; ENOXIMONE; ETOMIDATE; FENTANYL; GLUCOSE; INOTROPIC AGENT; INSULIN; KETAMINE; MILRINONE; MORPHINE; OPIATE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; POTASSIUM; SEVOFLURANE; STREPTOKINASE; SUFENTANIL;

ANESTHESIOLOGICAL TECHNIQUES; ARTERY STEAL SYNDROME; CONFERENCE PAPER; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DISEASE CLASSIFICATION; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG EFFECT; GENERAL ANESTHESIA; HEART ARREST; HEART ARRHYTHMIA; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART PROTECTION; HEMODYNAMIC MONITORING; HIGH RISK PATIENT; HUMAN; HYDRATION; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; HYPOTENSION; MYOCARDIAL DISEASE; OXYGEN THERAPY; PATHOPHYSIOLOGY; PATIENT MONITORING; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PREOPERATIVE TREATMENT; RESPIRATORY CHAIN; RESTRICTIVE CARDIOMYOPATHY; SURGICAL RISK; TACHYCARDIA; VASODILATATION;

EID: 0037705638     PISSN: 10892532     EISSN: None     Source Type: Journal    
DOI: 10.1177/108925320300700110     Document Type: Conference Paper

References (65)

1. Eagle KA, Berger PB, Calkins H, et al: ACC/AHA Guideline Update for Perioperative Cardiovascular Evaluation for Noncardiac Surgery-Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Anesth Analg 94:1052-1064, 2002.
2. Shoemaker WC: Cardiorespiratory patterns of surviving and non-surviving postoperative surgical patients. Surg Gynecol Obstet 134:801-814, 1972.
3. Shoemaker WC, Appel PL, Bland R: Use of physiological monitoring to predict outcome and to assist in clinical decisions in critically ill postoperative patients. Am J Surg 1:43-50, 1983.
4. Shoemaker WC, Appel PL, Krarn HB, et al: Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 94:1176-1186, 1983.
5. Boyd O, Bennett ED: Enhancement of perioperative tissue perfusion as a therapeutic strategy for major surgery. New Horiz 4:453-465, 1996.
6. Boyd O, Grounds RM, Bennett ED: A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 270:2699-2707, 1993.
7. Guest JF, Boyd O, Hart WM, Grounds RM, et al: A cost analysis of a treatment policy of a deliberate perioperative increase in oxygen delivery in high-risk surgical patients. Intensive Care Med 23:85-90, 1997.
8. Zaugg M, Tagliente T, Lucchinetti E, et al: Beneficial effects from beta-adrenergic blockade in elderly patients undergoing noncardiac surgery. Anesthesiology 91:1674-1686, 1999.
9. Raby KE, Brull SJ, Timimi F, et al: The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesth Analg 88:477-482, 1999.
10. Poldermans D, Boersma E, Bax JJ, et al: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341:1789-1794, 1999.
11. Warltier DC: Beta-adrenergic-blocking drugs: Incredibly useful, incredibly underutilized. Anesthesiology 88:2-5, 1998.
12. Metro M, Nodari S, D'Aloia A, et al: A rationale for the use of beta-blockers as standard treatment for heart failure. Am Heart J 139:511-521, 2000.
13. Braunwald E: Expanding indications for beta-blockers in heart failure. N Engl J Med 344:1711-1712, 2001.
14. Metro M, Giubbini R, Nodari S, et al: Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation 102:546-551, 2001.
15. Packer M, Coats AJ, Fowler MB, et al: Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651-1658, 2001
16. Reiz S, Balfors E, Swensen MB, et al: Isoflurane- a powerful coronary vasodilator in patients with coronary artery disease. Anesthesiology 59:91-97, 1983.
17. Warltier DC, Al-Wathiqui MH, Kampine JR, Schmeling WT: Recovery of contractile function of "stunned" myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. Anesthesiology 69:552-565, 1988.
18. ATP) channels. Anesthesiology 85:794-807, 1996.
19. Karsten JR, Schmeling TJ, Pagel PS, Gross GJ, et al: Isoflurane mimics ischemic preconditioning via activation of K(ATP) channels: Reduction of myocardial infarct size with an acute memory phase. Anesthesiology 87:361-370, 1997.
20. Canon BA, Gamperl AK, Slocum RE, Hickey RF: Anesthetic-induced preconditioning: Previous administration of isoflurane decreases myocardial infarct size in rabbits. Anesthesiology 87:1182-1190, 1997.
21. Belhomme D, Peynet J, Louzy M, et al: Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 100:II-340-II-344, 1999.
22. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136, 1986.
23. Laskey WK: Beneficial impact of preconditioning during PTCA on creating kinase release. Circulation 99:2085-2089, 1999.
24. ATP) channels. Anesthesiology 85:794-807, 1996.
25. Roscoe AK, Christensen JD, Lynch C: Isoflurane, but not halothane, induces protection of human myocardium via adenosine A1 receptors and adenosine triphosphate-sensitive potassium channels. Anesthesiology 92:1692-1670, 2000.
26. Piriou V, Chiari R, Knezynski S, et al: Prevention of isoflurane-induced preconditioning by 5-hydroxydecanoate and gadolinium. Anesthesiology 93:756-764, 2000.
27. Toller WG, Kersten JR, Pagel PS, Hettrick DA, et al: Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology 91:1437-1446, 1999.
28. Toller WG, Gross ER, Kersten JR, et al: Sarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels: Mechanism of desflurane-induced cardioprotection. Anesthesiology 92:1731-1739, 2000.
29. ATP channels via multiple signaling pathways. Anesthesiology 97:4-14, 2002.
30. ATP channel activity and cardiomyocyte protection. Anesthesiology 97:15-23, 2002.
31. Kwok W, Martinelli A, Fujimoto K, et al: Differential modulation of the cardiac ATP-sensitive potassium channel by volatile anesthetics. Anesthesiology 97:50-56, 2002.
32. ATP channel. Anesthesiology 97:57-65, 2002.
33. Hanouz J, Yvon A, Massetti M, et al: Mechanisms of desflurane-induced preconditioning in isolated human right atrium in vitro. Anesthesiology 97:33-4, 2002.
34. De Hert S, ten Broecke R, Mertens E, et al: Sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology 97:42-49, 2002.
35. Haroun-Bizri S, Khoury SS, Chehab IR, Kassas CM, et al: Does isoflurane optimize myocardial protection during cardiopulmonary bypass? J Cardiothorac Vasc Anesth 15:418-421, 2001.
36. Penta de Peppo A, Polisca R, Tomai F, et al: Recovery of LV contractility in man is enhanced by preischemic administration of enflurane. Ann Thorac Surg 68:112-118, 1999.
37. Lowenstein E, Hallowell R, Levlne FH, et al: Cardiovascular response to large doses of intravenous morphine in man. N Engl J Med 281:1389-1393, 1969.
38. Lowenstein E: Morphine 'anesthesia' - a perspective. Anesthesiology 35:563-565, 1971.
39. Lowenstein E, Philbin DM: Narcotic 'anesthesia' in the Eighties. Anesthesiology 55:195-197, 1981.
40. Schultz JE, Gross GJ: Opioids and cardioprotection. Pharmacol Ther 89:123-37, 1981.
41. Genade S, Moolman JA, Lochner A: Opioid receptor stimulation acts as mediator of protection in ischaemic preconditioning. Cardiovasc J S Afr 12:8-16, 2001.
42. Sigg DC, Coles JA, Gallagher WJ, Oeltgen PR, et al: Opioid preconditioning: Myocardial function and energy metabolism. Ann Thorac Surg 72:1576-1582, 2001.
43. Schultz JE, Hsu AK, Gross GJ: Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart Circ Res 78:1100-1104, 1996.
44. Cohen MV, Yang XM, Liu GS, Heusch G, et al: Acetylcholine, bradykinin, opioids, and phenylephrine, but not adenosine trigger preconditioning by generating free radicals and opening mitochondrial K(ATP) channels. Circ Res 89:273-278, 2001.
45. ATP channels. Circ Res 84:846-851, 1999.
46. ATP channels. Cfc Res 25;84:1396-1400, 1999.
47. Ocana M, Del Pozo E, Barrios M, Robels LI, et al: An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharrnacol 186:377-378, 1990.
48. Raffa RB, Martinez RP: The "glibenclamide-shift"of centrally-acting antinociceptive agents in mice. Brain Res 67:277-282, 1995.
49. Welch SP, Dunlow LD: Antinociception activity of intrathecally administered potassium channel openers and opioid agonists: A common mechanism of action. J Pharmacol Exp Ther 267:390-399, 1993.
50. Robels LL, Barrios M, Baeyens JM: ATP-sensitive K+ channel openers inhibit morphine withdrawal. Eur J Pharmacol 251:113-115, 1994.
51. Takasaki Y, Wolff RA, Chien GL, van Winkle DM: Met5-enkephalin protects isolated adult rabbit cardiomyocytes via delta-opioid receptors. Am Physiol 277:H2442-H2450, 1999.
52. Sigg DC, Coles JA, Oeltgen PR, Laizzo PA: Role of delta-opioid receptor agonists on infarct size reduction in swine. Am J Physiol Heart Circ Physiol 282:H1953-H1960, 2002.
53. Bolling SF, Badhwar V, Schwartz CF, et al: Opioids confer myocardial tolerance toischemia: Interaction of delta opioid agonists and antagonists. J Thorac Cardiovasc Surg 122:476-481, 2001.
54. ATP channel linked mechanisms in rats. Br J Anaesth 84:204-214, 2000.
55. Downey JM, Cohen MV: Signal transduction in ischemic preconditioning, in Sidman S, Beyar R (eds): Analytical and Quantitative Cardiology. New York: Plenum Press, 1997, pp 30-55.
56. Cahill CM, White TD, Sawynok J: Synergy between μ/δ-opioid receptors mediate adenosine release from spinal cord synaptosomes. Eur J Pharmacol 298:45-49, 1996.
57. Mantle JA, Rogers WJ, Smith LR, et al: Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: Results from a randomized clinical trial. Am Heart J 102:313-324, 1981.
58. Rackley CE, Rogers RO, Rogers WJ, et al: Clinical experience with glucose-insulin-potassium therapy in acute myocardial infarction. Am Heart J 102:1038-1049, 1981.
59. Neely JR, Grotyohann LV: Role of glycolytic products in damage to ischemic myocardium: Dissociation of adenosine triphosphate levels and recovery of perfused ischemic hearts. Circ Res 55:816-816, 1984.
60. Fath-Ordoubadi F, Beatt KJ: Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials. Circulation 96:1152-1156, 1997.
61. Malmburg K: Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Br Med J 314:1512-151, 1997.
62. Diaz R, Paolasso EA, Piegas LS, et al: Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiologicos Latinoamerica) Collaborative Group. Circulation 98:2227-2234, 1998.
63. Satler LF, Green CE, Kent KM, et al: Metabolic support during coronary reperfusion. Am Heart J 114:54-58, 1987.
64. Oliver MF, Opie LH: Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 343:155-158, 1994.
65. Rao V, Meranta F, Weisen RD, et al: Insulin stimulates pyruvate dehydrogenase and protects human ventricular myocytes from simulated ischemia. J Thorac Cardiovasc Surg 116:485-494, 1998.